Literature DB >> 22569721

Methylphenidate for the amelioration of cancer-associated fatigue.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22569721     DOI： 10.1007/s00520-012-1488-6

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  6 in total

1.  Quality of life, fatigue and depression in Italian long-term breast cancer survivors.

Authors:  Francesca Romito; Claudia Cormio; Francesco Giotta; Giuseppe Colucci; Vittorio Mattioli
Journal:  Support Care Cancer       Date:  2012-03-08       Impact factor: 3.603

2.  Factors associated with response to methylphenidate in advanced cancer patients.

Authors:  Sriram Yennurajalingam; J Lynn Palmer; Ray Chacko; Eduardo Bruera
Journal:  Oncologist       Date:  2011-01-31

3.  Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.

Authors:  Eduardo Bruera; Vicente Valero; Larry Driver; Loren Shen; Jie Willey; Tao Zhang; J Lynn Palmer
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

4.  Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: results of a pilot study.

Authors:  Juan F Cueva; Marcos Calvo; Urbano Anido; Luis León; Elena Gallardo; Carmen Areses; Beatriz Bernárdez; Lucía Gayoso; Jorge García; María Jesús Lamas; Teresa Curiel; Francisca Vázquez; Sonia Candamio; Yolanda Vidal; Francisco Javier Barón; Rafael López
Journal:  Invest New Drugs       Date:  2010-09-16       Impact factor: 3.850

5.  Methylphenidate for fatigue in ambulatory men with prostate cancer.

Authors:  Andrew J Roth; Christian Nelson; Barry Rosenfeld; Howard Scher; Susan Slovin; Michael Morris; Noelle O'Shea; Gabrielle Arauz; William Breitbart
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

6.  Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer.

Authors:  Rhonda L Johnson; Ingrid Block; Michael A Gold; Stephen Markwell; Melanie Zupancic
Journal:  Psychooncology       Date:  2010-09       Impact factor: 3.894
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.